跳转至内容
Merck
CN

03-308

Magna ChIRP® NEAT1 lncRNA探针套装

The Magna ChIRP NEAT1 lncRNA Probe Set contains 33 predesigned 20-mer DNA oligonucleotides tiled along and complementary to the sequence of human lncRNA NEAT1.

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12161503
NACRES:
NA.52
eCl@ss:
32161000
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Magna ChIRP® NEAT1 lncRNA探针套装, The Magna ChIRP NEAT1 lncRNA Probe Set contains 33 predesigned 20-mer DNA oligonucleotides tiled along and complementary to the sequence of human lncRNA NEAT1.

manufacturer/tradename

Magna ChIRP®

technique(s)

DNA sequencing: suitable
RNA extraction: suitable (nuclear function kit)
RNA purification: suitable (with magnetic beads)
activity assay: suitable (protein interaction)
nucleic acid detection: suitable (RNA)
protein purification: suitable (protein determination)

shipped in

dry ice

Quality Level

相关类别

Application

Magna ChIRP NEAT1 lncRNA 探针组包含 33 个预先设计的 20-mer DNA 寡核苷酸,与人 lncRNA NEAT1 的序列平铺并互补。
研究类别
表观遗传学&核功能

Disclaimer

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

General description

ChIRP(通过 RNA 纯化分离染色质)允许使用染色质相关 RNA 作为生物素化反义探针的靶标来回收 DNA 和蛋白质的特定片段。Magna ChIRP NEAT1 lncRNA 探针组包含 33 个预先设计的 20-mer DNA 寡核苷酸,与人 lncRNA NEAT1 的序列平铺并互补。所有探针均在 3-prime 末端被生物素 TEG 标记。寡核苷酸被分为两个库(偶数和奇数),并提供即用型用于 ChIRP 方法。该探针组与 Maga ChIRP 试剂盒完全兼容(货号17-10494 和 17-10495)

Physical form

50 µM 生物素-TEG 标记的 20-mer DNA 寡核苷酸,其中含有 10 mM Tris-HCl,1mM EDTA,pH 8.0

Preparation Note

收到后,储存于 -20°C。 避免反复冻融。如果储存和处理得当,该产品自收到之日起可稳定保存 6 个月。

Legal Information

MAGNA CHIRP is a registered trademark of Merck KGaA, Darmstadt, Germany

存储类别

10 - Combustible liquids

法规信息

监管及禁止进口产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

相关内容

"Cancer research giving you mixed signals? Signaling molecules are deeply embedded in processes associated with cancer. The study of signaling pathways is nearly synonymous with cancer research. Elucidating the various cellular and molecular mechanisms of cancer requires high quality research tools that give you precise, reproducible data. At EMD Millipore, our scientists are dedicated to developing and delivering thoroughly tested and validated tools for life science research."

Historically chromatin was considered to contain only DNA, histones, non-histone proteins and transiently associated mRNAs. While this remains true, current data suggest that a variety of non-coding RNAs (e.g. long non-coding RNAs, enhancer RNAs and even miRNAs) also associate with chromatin and serve regulatory functions.

Cancer is a complex disease manifestation. At its core, it remains a disease of abnormal cellular proliferation and inappropriate gene expression. In the early days, carcinogenesis was viewed simply as resulting from a collection of genetic mutations that altered the gene expression of key oncogenic genes or tumor suppressor genes leading to uncontrolled growth and disease (Virani, S et al 2012). Today, however, research is showing that carcinogenesis results from the successive accumulation of heritable genetic and epigenetic changes. Moreover, the success in how we predict, treat and overcome cancer will likely involve not only understanding the consequences of direct genetic changes that can cause cancer, but also how the epigenetic and environmental changes cause cancer (Johnson C et al 2015; Waldmann T et al 2013). Epigenetics is the study of heritable gene expression as it relates to changes in DNA structure that are not tied to changes in DNA sequence but, instead, are tied to how the nucleic acid material is read or processed via the myriad of protein-protein, protein-nucleic acid, and nucleic acid-nucleic acid interactions that ultimately manifest themselves into a specific expression phenotype (Ngai SC et al 2012, Johnson C et al 2015). This review will discuss some of the principal aspects of epigenetic research and how they relate to our current understanding of carcinogenesis. Because epigenetics affects phenotype and changes in epigenetics are thought to be key to environmental adaptability and thus may in fact be reversed or manipulated, understanding the integration of experimental and epidemiologic science surrounding cancer and its many manifestations should lead to more effective cancer prognostics as well as treatments (Virani S et al 2012).

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持